Mesenchymal stem cells in autism spectrum and neurodevelopmental disorders: pitfalls and potential promises
Authors:
- 31 July 2015
- journal article
- review article
- Published by Taylor & Francis in The World Journal of Biological Psychiatry
- Vol. 16 (6) , 368-375
Abstract
Objectives. In this conceptual review, the authors discuss the promises and pitfalls in the use of mesenchymal stem cells as a potential experimental therapeutic for autism spectrum and other neurodevelopmental disorders. Methods. The relevant literature in autism spectrum disorders and other neurodevelopmental disorders regarding immune dysregulation and neuroinflammation and relevant therapeutics with mesenchymal stem cell infusion is reviewed. The relevant literature pertaining to mesenchymal stem cells and their clinical applications is also reviewed. Results. It is proposed that immune dysregulation and neuroinflammation play a role in the aetiology of autism spectrum disorders. Mesenchymal stem cells have been shown to have immune-modulating capabilities and are neuroprotective. There are three international studies that have utilized mesenchymal stem cell infusions as a treatment for children with autism spectrum disorders, all of which demonstrated improvement in autism rating scale scores, although each study has limitations which are described. Conclusions. Mesenchymal stem cell transplantation for the treatment of autism spectrum disorders is a novel approach that deserves further investigation, however substantial methodological and theoretical challenges and pitfalls remain before this can be considered a viable therapeutic option.Keywords
This publication has 42 references indexed in Scilit:
- Inflammatory profiles in the BTBR mouse: How relevant are they to autism spectrum disorders?Brain, Behavior, and Immunity, 2015
- The role of microglia in brain maintenance: implications for Rett syndromeTrends in Immunology, 2013
- Autologous bone marrow-derived mesenchymal stromal cell treatment for refractory luminal Crohn's disease: results of a phase I studyGut, 2010
- Mesenchymal stem cells: biological properties and clinical applicationsExpert Opinion on Biological Therapy, 2010
- Gene Expression Analysis of Tuberous Sclerosis Complex Cortical Tubers Reveals Increased Expression of Adhesion and Inflammatory FactorsBrain Pathology, 2010
- Immunosuppression by mesenchymal stem cells: mechanisms and clinical applicationsStem Cell Research & Therapy, 2010
- Impaired hippocampus-dependent and -independent learning in IL-6 deficient miceBehavioural Brain Research, 2009
- Bone Marrow-Derived Mesenchymal Stem Cells Promote Neuronal Networks with Functional Synaptic Transmission After Transplantation into Mice with NeurodegenerationStem Cells, 2007
- Autologous mesenchymal stem cell transplantation in stroke patientsAnnals of Neurology, 2005
- Stem cell repair of central nervous system injuryJournal of Neuroscience Research, 2002